Rare bleeding disorders (RBDs) are autosomal recessive diseases including the inherited deficiencies of coagulation factors such as fibrinogen, factor (F) II, FV, FV + FVIII, FVII, FX, FXI, FXIII, and multiple deficiency of vitamin K-dependent factors, with clinical manifestations ranging from mild to severe. They represent 3 to 5% of all the inherited coagulation deficiencies with a prevalence in the general population varying between 1 in 500,000 and 1 in 2 million, being higher in areas where consanguineous marriages are diffuse. Despite the progress made in past years, as a consequence of the rarity of these deficiencies, the type and severity of bleeding symptoms, the underlying molecular defects, the actual management of bleeding episodes and particularly the prophylactic treatment in patients affected with RBDs are not well established. In this introductory article, the main features, diagnosis, available treatment options, and treatment complications of RBDs will be discussed

Introduction. Rare bleeding disorders : general aspects of clinical features, diagnosis, and management [Recensione] / F. Peyvandi, R. Palla, M. Menegatti, P.M. Mannucci. - In: SEMINARS IN THROMBOSIS AND HEMOSTASIS. - ISSN 0094-6176. - 35:4(2009 Jun), pp. 349-355. [10.1055/s-0029-1225757]

Introduction. Rare bleeding disorders : general aspects of clinical features, diagnosis, and management

F. Peyvandi
Primo
;
R. Palla
Secondo
;
M. Menegatti
Penultimo
;
P.M. Mannucci
Ultimo
2009

Abstract

Rare bleeding disorders (RBDs) are autosomal recessive diseases including the inherited deficiencies of coagulation factors such as fibrinogen, factor (F) II, FV, FV + FVIII, FVII, FX, FXI, FXIII, and multiple deficiency of vitamin K-dependent factors, with clinical manifestations ranging from mild to severe. They represent 3 to 5% of all the inherited coagulation deficiencies with a prevalence in the general population varying between 1 in 500,000 and 1 in 2 million, being higher in areas where consanguineous marriages are diffuse. Despite the progress made in past years, as a consequence of the rarity of these deficiencies, the type and severity of bleeding symptoms, the underlying molecular defects, the actual management of bleeding episodes and particularly the prophylactic treatment in patients affected with RBDs are not well established. In this introductory article, the main features, diagnosis, available treatment options, and treatment complications of RBDs will be discussed
Bleeding symptoms; Coagulation disorders; Genotypic diagnosis; Phenotypic diagnosis; Rare bleeding disorders; Rare coagulation disorders; Replacement therapy
Settore MED/09 - Medicina Interna
giu-2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
s-0029-1225757[1].pdf

accesso solo dalla rete interna

Tipologia: Publisher's version/PDF
Dimensione 114.39 kB
Formato Adobe PDF
114.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/71119
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 109
  • ???jsp.display-item.citation.isi??? 103
social impact